176 related articles for article (PubMed ID: 8645362)
1. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
Igau B; Lestavel S; Clavey V; Slomianny C; Drouin P; Bresson R; Fruchart JC; Duriez P; Fiévet C
Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
[TBL] [Abstract][Full Text] [Related]
3. Accessibility of human apolipoprotein B-100 epitopes in insulin-dependent diabetes: relation with the surface lipid environment of atherogenic particles.
Ziegler O; Méjean L; Igau B; Fruchart JC; Drouin P; Fiévet C
Diabetes Metab; 1996 Jun; 22(3):179-84. PubMed ID: 8697305
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E.
Bard JM; Delattre-Lestavel S; Clavey V; Pont P; Derudas B; Parra HJ; Fruchart JC
Biochim Biophys Acta; 1992 Jul; 1127(2):124-30. PubMed ID: 1322706
[TBL] [Abstract][Full Text] [Related]
6. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
[TBL] [Abstract][Full Text] [Related]
7. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins.
Shin MJ; Blanche PJ; Rawlings RS; Fernstrom HS; Krauss RM
Am J Clin Nutr; 2007 Jun; 85(6):1527-32. PubMed ID: 17556688
[TBL] [Abstract][Full Text] [Related]
9. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.
Young SG; Peralta FP; Dubois BW; Curtiss LK; Boyles JK; Witztum JL
J Biol Chem; 1987 Dec; 262(34):16604-11. PubMed ID: 3680266
[TBL] [Abstract][Full Text] [Related]
11. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.
Zawadzki Z; Tercé F; Seman LJ; Theolis RT; Breckenridge WC; Milne RW; Marcel YL
Biochemistry; 1988 Nov; 27(22):8474-81. PubMed ID: 2468359
[TBL] [Abstract][Full Text] [Related]
12. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
[TBL] [Abstract][Full Text] [Related]
13. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
14. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
[TBL] [Abstract][Full Text] [Related]
16. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function.
Marcel YL; Hogue M; Weech PK; Davignon J; Milne RW
Arteriosclerosis; 1988; 8(6):832-44. PubMed ID: 2461695
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein abnormalities in chronic haemodialysis patients.
Parsy D; Dracon M; Cachera C; Parra HJ; Vanhoutte G; Tacquet A; Fruchart JC
Nephrol Dial Transplant; 1988; 3(1):51-6. PubMed ID: 3132640
[TBL] [Abstract][Full Text] [Related]
19. [The important role of apolipoprotein C-III in lipoprotein metabolism].
Fruchart JC; Duriez P
C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
